100 related articles for article (PubMed ID: 7889495)
21. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease.
Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS
Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407
[TBL] [Abstract][Full Text] [Related]
22. Isoenzymes A and B of N-acetyl-beta-D-hexosaminidase in serum and urine of patients with pancreatic cancer.
Szajda SD; Snarska J; Jankowska A; Puchalski Z; Zwierz K
Hepatogastroenterology; 2008; 55(82-83):695-8. PubMed ID: 18613436
[TBL] [Abstract][Full Text] [Related]
23. Enzyme activities of collagen peptidase (CP), monoaminoxidase (MAO) and N-acetyl-beta-D-glucosaminidase (beta-NAG) as fibrosis marker in chronic liver diseases.
Müller A; Zollmann C; Machnik G; Krombholz B; Reinhardt M; Jorke D
Dtsch Z Verdau Stoffwechselkr; 1988; 48(1):27-34. PubMed ID: 2836153
[TBL] [Abstract][Full Text] [Related]
24. Serum isoenzymes in cancer diagnosis and management.
Mercer DW
Immunol Ser; 1990; 53():613-29. PubMed ID: 2100575
[TBL] [Abstract][Full Text] [Related]
25. [Clinical value of determining the N-acetyl-beta-D-glucosaminidase activity in joint diseases].
Zborovskiĭ AB; Marte'mianov VF; Shil BCh
Revmatologiia (Mosk); 1989; (3):21-4. PubMed ID: 2609055
[TBL] [Abstract][Full Text] [Related]
26. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
27. [Urinary N-acetyl-beta-D-glucosaminidase and its isoenzymes in smoking and non-smoking workers at copper foundry occupational co-exposed to arsenic cadmium and lead].
Milnerowicz H; Bizoń A; Witt K; Antonowicz-Juchniewicz J; Andrzejak R
Przegl Lek; 2008; 65(10):518-21. PubMed ID: 19189537
[TBL] [Abstract][Full Text] [Related]
28. A study of serum glycosidases in cancer.
Severini G; Diana L; Di Giovannandrea R; Tirelli C
J Cancer Res Clin Oncol; 1995; 121(1):61-3. PubMed ID: 7860621
[TBL] [Abstract][Full Text] [Related]
29. Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients.
Soria JC; Gauthier LR; Raymond E; Granotier C; Morat L; Armand JP; Boussin FD; Sabatier L
Clin Cancer Res; 1999 May; 5(5):971-5. PubMed ID: 10353728
[TBL] [Abstract][Full Text] [Related]
30. Renal tubular dysfunction and urinary zinc excretion in breast cancer patients treated with anthracycline-based combination chemotherapy.
Králícková P; Melichar B; Malír F; Roubal T
J Exp Clin Cancer Res; 2004 Dec; 23(4):579-84. PubMed ID: 15743027
[TBL] [Abstract][Full Text] [Related]
31. [The value of the free hydroxyproline and the N-acetyl-beta- glucosaminidase for the observation of the course of malignant tumors].
Ruffert K; Müller A; Lange H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1986; 113(3):329-42. PubMed ID: 2428707
[TBL] [Abstract][Full Text] [Related]
32. Stabilities of N-acetyl-beta-D-glucosaminidase (NAG) isoenzymes in urine: advantage of NAG isoenzyme B measurement in clinical applications.
Morita A; Numata Y; Kosugi Y; Noto A; Takeuchi N; Uchida K
Clin Chim Acta; 1998 Nov; 278(1):35-43. PubMed ID: 9877122
[TBL] [Abstract][Full Text] [Related]
33. The pretreatment plasma level and diagnostic utility of M-CSF in benign breast tumor and breast cancer patients.
Ławicki S; Szmitkowski M; Wojtukiewicz M
Clin Chim Acta; 2006 Sep; 371(1-2):112-6. PubMed ID: 16631152
[TBL] [Abstract][Full Text] [Related]
34. [The value of evaluating tumor markers: CA 15-3 and ferritin in blood serum of patients grouped as "high risk" for breast cancer].
Kokocińska D; Widala E; Donocik J; Nolewajka E
Przegl Lek; 1999; 56(10):664-7. PubMed ID: 10695382
[TBL] [Abstract][Full Text] [Related]
35. Monocyte tissue factor levels in cancer patients.
Lwaleed BA; Francis JL; Chisholm M
Saudi Med J; 2000 Aug; 21(8):722-9. PubMed ID: 11423883
[TBL] [Abstract][Full Text] [Related]
36. Elevation of serum riboflavin carrier protein in breast cancer.
Rao PN; Levine E; Myers MO; Prakash V; Watson J; Stolier A; Kopicko JJ; Kissinger P; Raj SG; Raj MH
Cancer Epidemiol Biomarkers Prev; 1999 Nov; 8(11):985-90. PubMed ID: 10566553
[TBL] [Abstract][Full Text] [Related]
37. [Isoenzyme P of N-acetyl-beta-glucosaminidase in sera from patients with liver diseases (author's transl)].
Pott G; Eberhardt G; Gerlach U
Klin Wochenschr; 1978 Jul; 56(13):681-2. PubMed ID: 672139
[TBL] [Abstract][Full Text] [Related]
38. Serum ostase in the follow-up of breast cancer patients.
Marchei P; Santini D; Bianco V; Chiodini S; Reale MG; Simeoni F; Marchei GG; Vecchione A
Anticancer Res; 1995; 15(5B):2217-22. PubMed ID: 8572628
[TBL] [Abstract][Full Text] [Related]
39. Combined measurement of serum sialyl Lewis X with serum CA15-3 in breast cancer patients.
Kurebayashi J; Nomura T; Hirono M; Okubo S; Udagawa K; Shiiki S; Ikeda M; Nakashima K; Tanaka K; Sonoo H
Jpn J Clin Oncol; 2006 Mar; 36(3):150-3. PubMed ID: 16520359
[TBL] [Abstract][Full Text] [Related]
40. Quantitative determination of telomerase activity in breast cancer and benign breast diseases.
Simícková M; Nekulová M; Pecen L; Cernoch M; Vagundová M; Pacovský Z
Neoplasma; 2001; 48(4):267-73. PubMed ID: 11712677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
